Delivering An Econsent Solution To Support Patients, Sites, And Study Teams

By Tim Davis ,VP of Strategy, MyVeeva for Patients, Veeva Systems, Inc.

As the move towards the adoption of digital trials accelerates, sponsors need to be confident they are making the right technology choices. This means thinking beyond patient-facing applications and considering the end-to-end clinical trial process to streamline study execution and management for sites and study teams.

eConsent solutions are no exception. Sponsors must seek a solution that meets the needs of all stakeholders – patients, sites, and study teams – to ensure successful implementation and achieve the efficiencies that digitized trials have the potential to deliver.

Here are four ways that an end-to-end eConsent solution can streamline the set-up, completion, and review of consent for sites and study teams while providing a simple, engaging experience for patients.